Montelukast Etofylline Theophylline Tablets

Product Description

Levoice ET tablet Montelukast, combined with Etofylline and Theophylline, constitutes a medication regimen often prescribed for the management of asthma and other respiratory conditions. Montelukast, a leukotriene receptor antagonist, serves to block the action of leukotrienes, inflammatory mediators implicated in asthma pathogenesis. By inhibiting leukotriene receptors, Montelukast helps to reduce airway inflammation, bronchoconstriction, and mucus production, thereby providing relief from asthma symptoms and improving respiratory function.

Etofylline and Theophylline, on the other hand, are methylxanthine derivatives that function as bronchodilators by relaxing the smooth muscles of the bronchi and bronchioles, leading to widened airways and improved airflow. This bronchodilator effect helps to alleviate symptoms such as wheezing, shortness of breath, and chest tightness associated with asthma. Additionally, Etofylline and Theophylline possess mild anti-inflammatory properties, further contributing to the overall management of asthma.

While generally well-tolerated, this medication combination may cause side effects such as gastrointestinal upset, headache, or insomnia. It's essential for patients to adhere to the prescribed dosage and to report any adverse reactions or concerns to their healthcare provider promptly. Additionally, individuals with certain medical conditions or taking other medications should consult their doctor before initiating treatment with Montelukast, Etofylline, and Theophylline, to ensure safety and efficacy.